ALT
Closed
Altimmune Inc
4.23
+0.36 (+9.30%)
Last Update: 01 Jul 2025 23:25:00
Yesterday: 3.87
Day's Range: 3.77 - 4.23
Send
sign up or login to leave a comment!
When Written:
4.22
Altimmune Inc is a clinical-stage biopharmaceutical company that focuses on developing vaccines and therapeutics for infectious diseases and immune-mediated disorders. The company's lead product candidate is NasoVAX, a single-dose intranasal vaccine for influenza. Altimmune's other product candidates include AdCOVID, a single-dose intranasal vaccine for COVID-19, and HepTcell, a therapeutic vaccine for chronic hepatitis B. The company also has a pipeline of preclinical candidates for cancer immunotherapy and respiratory diseases. Altimmune is headquartered in Gaithersburg, Maryland, and was founded in 1997.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








